Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
vorinostat histone deacetylase 1 small molecule Successful target TTD , drugbank , DGIDB Lymphoma
T-Cell
Cutaneous[MeSHID:D016410]
Disease[MeSHID:D004194]
Recurrence (disease attribute)[MeSHID:D012008]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.58 approved,investigational inhibitor
vorinostat histone deacetylase 2 small molecule NA drugbank , DGIDB Lymphoma
T-Cell
Cutaneous[MeSHID:D016410]
Disease[MeSHID:D004194]
Recurrence (disease attribute)[MeSHID:D012008]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.61 approved,investigational inhibitor
vorinostat histone deacetylase 3 small molecule NA drugbank , DGIDB Lymphoma
T-Cell
Cutaneous[MeSHID:D016410]
Disease[MeSHID:D004194]
Recurrence (disease attribute)[MeSHID:D012008]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.59 approved,investigational inhibitor
vorinostat histone deacetylase 6 small molecule NA drugbank , DGIDB Lymphoma
T-Cell
Cutaneous[MeSHID:D016410]
Disease[MeSHID:D004194]
Recurrence (disease attribute)[MeSHID:D012008]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.66 approved,investigational inhibitor
vorinostat histone deacetylase 8 small molecule NA drugbank , DGIDB Lymphoma
T-Cell
Cutaneous[MeSHID:D016410]
Disease[MeSHID:D004194]
Recurrence (disease attribute)[MeSHID:D012008]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.44 approved,investigational inhibitor
vorinostat histone deacetylase 8 small molecule NA drugbank , DGIDB Lymphoma
T-Cell
Cutaneous[MeSHID:D016410]
Disease[MeSHID:D004194]
Recurrence (disease attribute)[MeSHID:D012008]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.44 approved,investigational unknown
click here to return to the previous page